| A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients (NCT00188305) | University Health Network, Toronto | 2005-01-01 |
| Molecular Genetic and Pathological Studies of Anal Tumors (NCT00267787) | Stanford University | 2004-09-01 |
| MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV (NCT00263055) | Sanofi | 2004-08-01 |
| MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. (NCT00147550) | Pfizer | 2004-02-01 |
| An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer (NCT00054912) | Epimmune | 2003-02-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. (NCT00056459) | Novartis | 2003-02-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer (NCT00056446) | Novartis Pharmaceuticals | 2003-01-01 |
| EPO906 Therapy in Patients With Advanced Colorectal Cancer (NCT00035087) | Novartis Pharmaceuticals | 2002-05-01 |
| Endo-Laparoscopic Approach Versus Conventional Open Surgery in Obstructing Left-sided Colon Cancer: RCT (NCT00654212) | Pamela Youde Nethersole Eastern Hospital | 2002-01-01 |
| Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer (NCT00826579) | University Hospital, Basel, Switzerland | 2000-05-01 |
| A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab (NCT00001805) | National Cancer Institute (NCI) | 1999-03-01 |
| MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer (NCT00275210) | Sanofi | 1998-10-01 |
| Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer (NCT00202111) | The Queen Elizabeth Hospital | 1998-01-01 |
| COlon Cancer Laparoscopic or Open Resection (NCT00387842) | Erasmus Medical Center | 1997-03-01 |
| Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers (NCT00579163) | Memorial Sloan Kettering Cancer Center | 1994-12-01 |
| Study Evaluating EKB-569 in Advanced Colorectal Cancer (NCT00072748) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer (NCT01477866) | University of Palermo | |
| Study Evaluating MAC-321 in Colorectal Cancer (NCT00063427) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Women's Health Initiative (WHI) (NCT00000611) | National Heart, Lung, and Blood Institute (NHLBI) | |